Characteristics of the earliest cross-neutralizing antibody response to HIV-1.

Mikell I, Sather DN, Kalams SA, Altfeld M, Alter G, Stamatatos L. · 2011

Read Characteristics of the earliest cross-neutralizing antibody response to HIV-1. by Mikell I, Sather DN, Kalams SA, Altfeld M, Alter G, Stamatatos L. (2011) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc3020924.txt.

Description

Mikell and colleagues charted when broadly cross-neutralising antibodies against HIV first appear, in a 2011 study following blood samples from soon after infection up to seven years. Such antibodies, able to block many virus variants, arise in only a minority of patients and are a vaccine design goal.

On average the broad response became visible about two and a half years in, rarely as early as one year, and seldom started after year three. Its arrival tracked with certain T cell activation marks and with virus levels in blood. The earliest broad activity aimed at few envelope targets, chiefly the patch the virus uses to grip its cell receptor.

Catalog record

CREATORMikell I, Sather DN, Kalams SA, Altfeld M, Alter G, Stamatatos L.
YEAR2011
COLLECTIONPAPERS
FORMATTXT
FILE SIZE65 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC3020924

Browse the full library · About the Tower of Babel